ArticleScientific reports2025
Intensified process based on reactive distillation for Triacetin production via glycerol esterification with acetic acid.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Defect-Engineered MOF-808-SOMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study investigated the valorization of glycerol through triacetin (TA) production via glycerol esterification with acetic acid using reactive distillation (RD). The conventional TA production typically involved multiple unit operations, leading to process complexity and high costs. A simplified TA production process based on the appropriate design for RD was developed. The simulation results, validated by a robust kinetic model, demonstrated the high accuracy to predict glycerol conversion and TA purity. The optimized RD required only 32 theoretical stages using an acetic acid to glycerol feed molar ratio of 3:1, glycerol feed at the 2nd stage, acetic acid feed at the 31st stage, a reflux ratio of 7, and a bottom to feed ratio of 0.25 under column pressure of 0.7 bar without an entrainer. This configuration achieved the remarkable performance, with a 99.20% glycerol conversion, 99.41% TA selectivity, and 99.00% TA purity. The number of unit operations of RD process was reduced to 50%, leading to acquiring only 79.16% of the capital cost as compared to the conventional method. This finding highlights the economic advantage of the RD process, offering a sustainable, cost-effective, and scalable alternative for large-scale TA production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.